Page last updated: 2024-12-10

galactose-6-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

galactose-6-phosphate: RN given refers to D-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3034794
CHEBI ID17733
SCHEMBL ID8488
MeSH IDM0115294

Synonyms (17)

Synonym
6665-00-5
CHEBI:17733
aldehydo-d-galactose 6-(dihydrogen phosphate)
d-galactose, 6-(dihydrogen phosphate)
6-o-phosphono-d-galactose
galactose-6-phosphate
DB03581
9FBEA297-CF39-432F-9160-9837FABA7C9E
[(2r,3s,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexyl] dihydrogen phosphate
SCHEMBL8488
glucose-6-phosphate (g6p)
bdbm197174
VFRROHXSMXFLSN-KCDKBNATSA-N
galactose 6-phosphate
DTXSID401314709
{[(2r,3s,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexyl]oxy}phosphonic acid
PD006796
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
D-galactose 6-phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1802033Fluorescence Binding Assay from Article 10.1021/acs.biochem.6b00638: \\Investigating the Reaction Mechanism of F420-Dependent Glucose-6-phosphate Dehydrogenase from Mycobacterium tuberculosis: Kinetic Analysis of the Wild-Type and Mutant Enzymes.\\2016Biochemistry, Oct-04, Volume: 55, Issue:39
Investigating the Reaction Mechanism of F
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (25.00)18.7374
1990's7 (35.00)18.2507
2000's5 (25.00)29.6817
2010's3 (15.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.68 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]